The Journal.

Trump's Tariffs Are Illegal. He's Got a Plan B.

In a 6-3 decision, the Supreme Court ruled that President Trump’s global tariffs are illegal. It is the first time the Supreme Court has definitively struck down one of Trump’s second-term policies, saying the president went too far in enacting his most sweeping tariffs without clear authorization from Congress. WSJ’s Gavin Bade unpacks the ruling and discusses Trump’s next steps. Ryan Knutson hosts. Further Listening: - Trump's Tariffs Force a New Era in Global Trade - How Tariffs Could End Italian Pasta in the U.S. - The Tariff Trade Off: Jobs vs. Higher Prices Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

In A Landmark Trial, Zuckerberg Takes the Stand

Yesterday, Meta CEO Mark Zuckerberg testified in a first-of-its-kind trial with one central question: Are social media platforms causing mental health disorders among young people? The plaintiff argues that platforms like Instagram are designed to keep children addicted, potentially bypassing long-standing legal shields that have protected tech companies in the past. WSJ’s Meghan Bobrowsky takes us inside the courtroom for Mark Zuckerberg’s testimony and explains why this trial could impact thousands of other cases. Ryan Knutson hosts. Further Listening: - The Battle Within Meta Over Chatbot Safety - “The Facebook Files’ from The Journal. Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Flu Shot Drama at the FDA

The Food and Drug Administration agreed to begin a review of biotech company Moderna’s application to make a new seasonal flu shot available. The decision comes after the FDA initially refused to review the company's application. It's a back and forth that reveals increased turmoil within the agency. WSJ’s Liz Essley Whyte takes us inside the FDA’s unexpected reversals and explores what’s next for the mRNA flu vaccine. Jessica Mendoza hosts.  Further Listening: - The FDA Commissioner on Vaccines and Public Trust - Breakfast Battle: The Cereal Industry vs MAHA Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Insiders Are Cashing In on Prediction Markets

Prediction markets like Polymarket and Kalshi are booming, but they’re facing questions about users betting on information that is not publicly available, from Super Bowl performances to geopolitical crises. Advocates for the platforms say they are "truth machines" but critics say they’re a new vehicle for insider trading. WSJ’s Caitlin Ostroff explains how users are making fortunes, and why regulators are starting to take notice. Ryan Knutson hosts. Further Listening: - How ‘The Joker’ Rigged the Texas Lottery - How Parlays Became the Biggest Bet in SportsSign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Viral Band Trying to Sing Its Way to a U.S. Visa

Boy Throb is a new boy band going viral on social media, but member Darshan Magdum is stuck in India. To get him to the U.S., the band needs to convince the United States government that Darshan qualifies for an "extraordinary ability" visa, the type of thing that’s often reserved for Olympians and scientists. WSJ’s Michelle Hackman explains the visa process and Boy Throb tells Jessica Mendoza about their unconventional quest to get their fourth member stateside. Further Listening: - Are Waymos Driving More Like Humans? - Lady Gaga, Low-Rise Jeans, and the Next Recession Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices